ZOGENIX, INC. 3 SEC Filings

Filed On	Filing
23 Sep 2020	Form 3: Waynick Denelle J, Director No securities owned
23 Sep 2020	Form 3: Stutts Mary E., Director No securities owned
23 Sep 2020	Form 3: Loewy Caroline M, Director No securities owned
21 Apr 2020	Form 3: Mitchell Shawnte, EVP, GC and Secretary No securities owned
05 Jul 2018	Form 3: Sagrolikar Ashish M, EVP & CHIEF COMMERCIAL OFFICER No securities owned
18 May 2017	Form 3: Edelman Joseph, 10% owner and 2 others Holds 3,272,649 shares of Common Stock
18 Jan 2017	Form 3: Smith Michael P, EVP, CFO, Treasurer & Sec. No securities owned
06 Jul 2015	Form 3: Farfel Gail M, EVP/Chief Development Officer No securities owned
06 Jul 2015	Form 3: Darcis Thierry J.p., EVP / General Manager, Europe Holds 34,000 shares of Common Stock
10 Feb 2015	Form 3: Tannenbaum Renee P, Director No securities owned
26 Mar 2014	Form 3: Breitmeyer James B, Director Holds 10,000 shares of Common Stock
18 Dec 2013	Form 3: Galer Bradley S., Chief Medical Officer Holds 1,500 shares of Common Stock
30 Nov 2012	Form 3: Shively Richard Scott, Chief Commercial Officer No securities owned
17 Jan 2012	Form 3: Kamdar Kim P., 10% owner Holds 11,000 shares of Common Stock
25 May 2011	Form 3: Wiggins Mark C, Director No securities owned
22 Nov 2010	Form 3: Chicago Growth Partners Ii L P, 10% owner and 2 others
22 Nov 2010	Form 3: Clarus Lifesciences I, L.p., 10% owner and 7 others
22 Nov 2010	Form 3: Thomas Mcnerney & Partners Lp, 10% owner and 9 others
22 Nov 2010	Form 3: Thomas Mcnerney & Partners Lp, 10% owner and 9 others
22 Nov 2010	Form 3: Thomas Mcnerney & Partners Lp, 10% owner and 9 others

Comments